Article Text

Download PDFPDF
Intensive insulin treatment reduced mortality and morbidity in critically ill patients

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

OpenUrlCrossRefPubMedWeb of Science

QUESTION: In patients who are critically ill, does normalisation of blood glucose concentrations with intensive insulin treatment reduce mortality and morbidity?

Design

Randomised (allocation concealed), blinded (patients, outcome assessors), controlled trial {with mean follow up of 23 days}*.

Setting

Surgical intensive care unit (ICU) at the university hospital in Leuven, Belgium.

Patients

1548 patients (mean age 63 y, 71% men) admitted to the ICU who were receiving mechanical ventilation. Patients were excluded if they were participating in other trials, were moribund, or had “do not resuscitate” orders. Follow up was 100%.

Intervention

Patients were assigned to receive intensive (n=765) or conventional (n=783) insulin treatment. Intensive treatment was insulin infusion that was started if the blood glucose concentration was > 6.1 mmol/l, and was …

View Full Text

Footnotes

  • Sources of funding: University of Leuven; Belgian Fund for Scientific Research; Belgian Foundation for Research in Congenital Heart Disease; and Novo Nordisk.

  • For correspondence: Dr G Van den Berghe, University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium. greta.vandenberghe{at}med.kuleuven.ac.be

  • A modified version of this abstract appears in ACP Journal Club.

  • * Information provided by author.